LibraGen signs partnership agreement with Pierre Fabre Medicament R&D
LibraGen will use its industrial biocatalysis know-how to carry out research into optimizing the synthesis of a pharmaceutical molecule
09-Jan-2006 -
LibraGen announced that it has signed a partnership agreement with the R&D department of Pierre Fabre Medicament, France's second largest independent pharmaceutical company. Under the terms of the agreement, LibraGen will use enzymatic technologies to optimize the synthesis of a molecule which is ...
biocatalysis
chemical synthesis